Medical Research · UT
The Cholangiocarcinoma Foundation
The Cholangiocarcinoma Foundation reported paying Stacie Lindsey, Ceo/founder, $210,488 in total compensation (FY 2024).
That places Stacie Lindsey at approximately the 53rd percentile among 17 similarly sized medical research nonprofits (median $198,614).
$6,918,626Total revenue (FY 2024)
$210,488Total executive compensation
53rdPercentile vs. peers
Setting executive pay for this board?
Generate a board-ready comparability report for The Cholangiocarcinoma Foundation — named comparables, percentiles, methodology, and the 26 CFR 53.4958-6 minutes language a board can use toward the rebuttable presumption.
Build the comparability report →Comparable medical research nonprofits
Compensation is normalized to UT cost of living (BEA Regional Price Parities); each organization's reported figure is on its linked 990.
| Organization | State | Revenue | Total comp |
|---|---|---|---|
| International Society For Stem Cell Rese | IL | $7,014,505 | $398,108 |
| The Roskamp Institute Inc | FL | $6,777,832 | $198,614 |
| Chicago Association For Research And Education In Science | IL | $6,586,905 | $172,722 |
| Biomedical Research Institute | NM | $6,572,325 | $134,282 |
| Caring Cross Inc | MD | $6,365,843 | $138,559 |
| Multidisciplinary Association For | CA | $7,480,253 | $172,692 |
| Institute For Protein Innovation Inc | MA | $7,481,529 | $692,035 |
| Center For Applied Rationality | CA | $6,329,582 | $160,517 |